norgestrel and n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide

norgestrel has been researched along with n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dunbar, S; Johnson-Levonas, AO; Lasseter, KC; Li, S; Miller, DL; Rosko, K; Schwartz, JI; Wagner, JA; Yuan, J	1

Trials

1 trial(s) available for norgestrel and n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide

Article	Year
Influence of taranabant, an orally active, highly selective, potent cannabinoid-1 receptor (CB1R) inverse agonist, on ethinyl estradiol and norelgestromin plasma pharmacokinetics. Journal of clinical pharmacology, 2009, Volume: 49, Issue:1 Topics: Administration, Oral; Adult; Amides; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Inverse Agonism; Ethinyl Estradiol; Female; Humans; Norgestrel; Oximes; Pyridines; Receptor, Cannabinoid, CB1; Young Adult	2009

Article

Year

Influence of taranabant, an orally active, highly selective, potent cannabinoid-1 receptor (CB1R) inverse agonist, on ethinyl estradiol and norelgestromin plasma pharmacokinetics.

Journal of clinical pharmacology, 2009, Volume: 49, Issue:1

Topics: Administration, Oral; Adult; Amides; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Inverse Agonism; Ethinyl Estradiol; Female; Humans; Norgestrel; Oximes; Pyridines; Receptor, Cannabinoid, CB1; Young Adult

2009